Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010

BACKGROUND: The purpose of this study was to evaluate the effects of cytoreductive nephrectomy (CN) and metastasectomies on the survival of patients with synchronous metastatic renal cell cancer (mRCC) using real-life, population-based national dataset. METHODS: Nationwide data, including all cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Laru, Lauri, Ronkainen, Hanna, Ohtonen, Pasi, Vaarala, Markku H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240260/
https://www.ncbi.nlm.nih.gov/pubmed/34183025
http://dx.doi.org/10.1186/s12957-021-02308-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240260/
https://www.ncbi.nlm.nih.gov/pubmed/34183025
http://dx.doi.org/10.1186/s12957-021-02308-0

Ejemplares similares